In the latest trading session, 0.45 million Neurogene Inc (NASDAQ:NGNE) shares changed hands as the company’s beta touched 1.51. With the company’s most recent per share price at $40.14 changed hands at -$31.39 or -43.88% at last look, the market valuation stands at $521.56M. NGNE’s current price is a discount, trading about -85.58% off its 52-week high of $74.49. The share price had its 52-week low at $12.49, which suggests the last value was 68.88% up since then. When we look at Neurogene Inc’s average trading volume, we note the 10-day average is 0.28 million shares, with the 3-month average coming to 136.18K.
Analysts gave the Neurogene Inc (NGNE) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.14. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NGNE as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Neurogene Inc (NASDAQ:NGNE) trade information
Instantly NGNE was in red as seen in intraday trades today. With action -37.67%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 107.12%, with the 5-day performance at -37.67% in the red. However, in the 30-day time frame, Neurogene Inc (NASDAQ:NGNE) is -19.32% down. Looking at the short shares, we see there were 0.93 million shares sold at short interest cover period of 6.53 days.
The consensus price target for the stock as assigned by Wall Street analysts is 54, meaning bulls need an upside of 25.67% from its recent market value. According to analyst projections, NGNE’s forecast low is 49 with 65 as the target high. To hit the forecast high, the stock’s price needs a -61.93% plunge from its current level, while the stock would need to soar -22.07% for it to hit the projected low.
Neurogene Inc (NGNE) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.09%. The 2024 estimates are for Neurogene Inc earnings to decrease by -251.00%, but the outlook for the next 5-year period is at 25.10% per year.
